Immusoft immusoft.com


Public lists: Smart Money VCs (6328)

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to human trials is a therapy for MPS I, a rare, genetic, lysosomal storage disease. ISP technology will be used to make patient's immune cells continually secrete a-L-iduronidase (IDUA).

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to human trials is a therapy for MPS I, a rare, geneti...Show all

Company (Alive / Active)

Phone: 206-931-0262

Fax:

454 N 34th St.

Seattle, 98103
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immusoft $8.8M Jan 5, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immusoft Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Vectors and methods for transducing b cells Jan 07, 2011 Jul 07, 2015 Patent
B cells for in vivo delivery of therapeutic agents Dec 18, 2015 Application
Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors Mar 14, 2014 Application